Differentiation of Multiple Sclerosis Subtypes: Implications for Treatment

ISSN： 1172-7047

Source： CNS Drugs, Vol.16, Iss.6, 2002-01, pp. : 405-418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis

Current Pharmaceutical Design, Vol. 12, Iss. 2, 2006-01 ,pp. : 241-249

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple sclerosis and its treatment

By Giovannoni Gavin Miller David H

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite

Multiple Sclerosis: Pathogenesis and Treatment

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 409-416

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Multiple Sclerosis

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 8, Iss. 3, 2009-07 ,pp. : 167-174

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs Treatment of Pain in Multiple Sclerosis

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite